Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
700 NE 13th St
Oklahoma City, OK 73104Phone+1 405-271-6000Fax+1 405-456-1560- Is this information wrong?
Education & Training
- Boston University Medical CenterResidency, Emergency Medicine, 1999 - 2002
- Mount Auburn HospitalInternship, Internal Medicine, 1998 - 1999
- Geisel School of Medicine at DartmouthClass of 1998
Certifications & Licensure
- TX State Medical License 2023 - 2026
- CO State Medical License 2024 - 2025
- OK State Medical License 2002 - 2024
- AR State Medical License 2018 - 2019
- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 21 citationsActivation of somatostatin receptor subtype 2 inhibits insulin secretion in the isolated perfused human pancreas.Francis C. Brunicardi, Atiya A, Stefan Moldovan, Timothy C. Lee, Shawn P. Fagan, Robert Kleinman, Thomas E. Adrian, David H. Coy, John H. Walsh, William E. Fisher> ;Pancreas. 2003 Nov 1
- Parenterally or enterally administered anti-somatostatin antibody induces increased gastrin in suckling rats.Martín, M. G., Wu, S. V., Ohning, G., Wong, H., Walsh, J. H.> ;Am J Physiol. 1994 Mar
- Peptide YY inhibition of rat gastric enterochromaffin-like cell function.Zeng, N., Walsh, J. H., Kang, T., Wu, S. V., Sachs, G.> ;Gastroenterology. 1997 Jan
- Join now to see all
Grant Support
- Cure: Digestive Diseases Research Center Pilot ProgramsNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Core--Antibody/RadioimmunoassayNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
- Gastric Neuropeptidases/Peptide Receptor InteractionsNational Institute Of Diabetes And Digestive And Kidney Diseases1998–1999
- Cure--Gastroenteric Biology CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Core--Antibody/Radioimmunoassay FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases1995–1999
- Hormonal Stimulation And Inhibition Of Gastric SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1999
- GastroenterologyNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1999
- Gastric Neuropeptidases--Peptide Receptor InteractionsNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1997
- Digestive Disease CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Hormonal Stimulation And Inhibition Of Gastric SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases1987–1994
- CURE Digestive Disease Core CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1990–1993
- Physiological Role Of Gastric NeuropeptidasesNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1992
- Peptic Ulcer CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1989
- International Conference On Gastroenteric BiologyNational Institute Of Diabetes And Digestive And Kidney Diseases1988
- Physiological Role Of Gastric NeuropeptidasesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Hormonal Stimulation And Inhibition Of Gastric SecretionNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- GastroenterologyNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
- Analysis And Purification Of Gastric PeptidesNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Hospital Affiliations
- OU HealthOklahoma City, Oklahoma
- Oklahoma City VA Medical CenterOklahoma City, Oklahoma
- INTEGRIS Baptist Medical CenterOklahoma City, Oklahoma
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: